Smart-Money SignalDistribution · 40/100— Insiders are net sellers over 90 days (-$306K, 16 sales vs 11 buys)
Revenue$99.3M
Net Income-$47.3M
EPS$-0.29
Market Cap$3.7B
Price Performance
Historical data including institutional events
Company Profile
F
Frederick Vogt
CEO & Executive Director
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
